Paulina Hill

Principal | Consulate General of Canada (CTA Boston)

Cambridge, MA, UNITED STATES

Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.

Biography

Paulina was on the healthcare team at Polaris Partners since 2012, and is now a Biotech investor at Omega Funds. Paulina is currently an observer on the board of Arrakis Therapeutics. Paulina previously served on the boards of Kala Pharmaceuticals (NASDAQ: KALA), Neuronetics (NASDAQ: STIM), Lyra Pharmaceuticals, Faraday Pharmaceuticals, Arsenal Medical and CAMP4 Therapeutics, where she was the founding CEO. Paulina completed her postdoctoral fellowship in Robert Langer’s lab in the Chemical Engineering department at the Massachusetts Institute of Technology. Paulina was the founding president of the MIT Postdoctoral Association and served on the MIT Intellectual Property Presidential Committee. Paulina completed her PhD in Molecular Medicine from the Wake Forest University School of Medicine and graduated magna cum laude from East Carolina University with a quadruple major in biochemistry, neuroscience, biology and chemistry.